Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Exercise  COVID-19 treatment studies for Exercise  C19 studies: Exercise  Exercise   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 47% Improvement Relative Risk Fernandez et al. Exercise for COVID-19 LATE TREATMENT Is late treatment with exercise beneficial for COVID-19? Retrospective 439 patients in Chile Lower mortality with exercise (p=0.018) Fernandez et al., J. Applied Physiology, doi:10.1152/japplphysiol.00544.2022 Favors exercise Favors inactivity
Intrahospital supervised exercise training improves survival rate among hypertensive COVID-19 patients
Fernandez et al., Journal of Applied Physiology, doi:10.1152/japplphysiol.00544.2022
Fernandez et al., Intrahospital supervised exercise training improves survival rate among hypertensive COVID-19 patients, Journal of Applied Physiology, doi:10.1152/japplphysiol.00544.2022
Feb 2023   Source   PDF  
  All Studies   Meta
Retrospective 439 severe COVID-19 hospitalized patients with hypertension, 201 receiving a supervised exercise program, showing significantly lower mortality with exercise. Exercise included of aerobic, breathing, and musculoskeletal exercises, 3 to 4 times per week. There were significantly more control patients on beta-adrenergic blockers and thiazide diuretics.
There are many possible mechanisms of action, including improved circulation, stress reduction, hormone regulation, improved sleep, increased antioxidant levels, and increased nitric oxide levels in the respiratory system. Over-exercising may be detrimental and lead to impaired immune function.
risk of death, 47.5% lower, RR 0.53, p = 0.02, high activity levels 16 of 201 (8.0%), low activity levels 62 of 238 (26.1%), NNT 5.5, adjusted per study, odds ratio converted to relative risk, multivariable.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Fernandez et al., 2 Feb 2023, retrospective, Chile, peer-reviewed, 10 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperExerciseAll
Abstract: 1 INTRAHOSPITAL SUPERVISED EXERCISE TRAINING IMPROVES SURVIVAL 2 RATE AMONG HYPERTENSIVE COVID-19 PATIENTS 3 **Francisco Fernandez1,2, **Manuel Vazquez-Muñoz3, Andrea Canals4, Alexis 4 Arce-Álvarez3, Camila Salazar-Ardiles1,7, Cristian Alvarez5, Rodrigo Ramirez- 5 Campillo5, Gregoire P. Millet6, Mikel Izquierdo7,8, *David C. Andrade1 6 7 8 9 10 11 12 13 14 15 16 1 Exercise Applied Physiology Laboratory, Centro de Investigación en Fisiología y Medicina de Altura, Departamento Biomedico, Facultad de Ciencias de la Salud, Universidad de Antofagasta, Antofagasta, Chile. 2Programa de Magister en Fisiología Clínica del Ejercicio, Facultad de Ciencias, Universidad Mayor, Santiago, Chile. 3Escuela de Kinesiología, Facultad de Odontología y Ciencias de la Rehabilitación, Universidad San Sebastián, Santiago, Chile. 4Unidad de Estadística, Departamento de Calidad, Clínica Santa María, Santiago, Chile. 5Exercise and Rehabilitation Sciences Laboratory, School of Physical Therapy, Faculty of Rehabilitation Sciences, Universidad Andres Bello, Santiago 7591538, Chile, 6Institute of Sport Sciences, University of Lausanne, CH1015, Lausanne, Switzerland, 7Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain. 8CIBER of Frailty and Healthy Aging (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain. 17 18 19 Running Head: intrahospital exercise and COVID-19 20 21 22 23 24 25 26 27 28 29 30 31 32 ** These authors contributed equally to this work. *Corresponding author: David C. Andrade, Ph.D. Exercise Applied Physiology Laboratory Centro de investigación en Fisiología y Medicina de Altura Departamento Biomedico Facultad de Ciencias de la Salud, Universidad de Antofagasta Antofagasta, Chile. Tel: +569 88928666 E-mail: 33 34 35 ABSTRACT 36 Among the people most affected by coronavirus disease 2019 (COVID-19) are 37 those suffering from hypertension (HTN). However, pharmacological therapies for 38 HTN are ineffective against COVID-19 progression and severity. It has been 39 proposed that exercise training (EX) could be used as post-COVID treatment, 40 which does not rule out the possible effects during hospitalization for COVID-19. 41 Therefore, we aimed to determine the impact of supervised EX on HTN patients 42 with COVID-19 during hospitalization. Among a total of 1,508 hospitalized COVID- 43 19 patients (confirmed by PCR), 439 subjects were classified as having HTN and 44 were divided into two groups: EX (n=201) and control (n=238) groups. EX (3 to 4 45 times per week during all hospitalizations) consisted of aerobic exercises (15 to 45 46 min) (i.e., walking); breathing exercises (10 to 15 min) (i.e., diaphragmatic 47 breathing, pursed-lip breathing, active abdominal contraction); and musculoskeletal 48 exercises (8–10 sets of 12–15 repetitions/week) (lifting dumbbells, standing up and 49 sitting, lumbar stabilization). Our data revealed that the EX (clinician: patient, 1:1 50 ratio) intervention was able to improve survival rates among controlled HTN 51 patients with COVID-19 during their hospitalization when compared to the control 52 group (chi-squared: 4.83; hazard ratio: 1.8; 95% CI: 1.117 to 2.899; p=0.027). 53 Multivariate logistic regression analysis revealed that EX was a prognostic..
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop